Ahn, B.-C.;                     Lee, J.H.;                     Kim, M.H.;                     Pyo, K.-H.;                     Lee, C.-k.;                     Lim, S.M.;                     Kim, H.R.;                     Cho, B.C.;                     Hong, M.H.    
        Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Cancers 2021, 13, 3096.
    https://doi.org/10.3390/cancers13123096
    AMA Style
    
                                Ahn B-C,                                 Lee JH,                                 Kim MH,                                 Pyo K-H,                                 Lee C-k,                                 Lim SM,                                 Kim HR,                                 Cho BC,                                 Hong MH.        
                Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Cancers. 2021; 13(12):3096.
        https://doi.org/10.3390/cancers13123096
    
    Chicago/Turabian Style
    
                                Ahn, Beung-Chul,                                 Ji Hyun Lee,                                 Min Hwan Kim,                                 Kyoung-Ho Pyo,                                 Choong-kun Lee,                                 Sun Min Lim,                                 Hye Ryun Kim,                                 Byoung Chul Cho,                                 and Min Hee Hong.        
                2021. "Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors" Cancers 13, no. 12: 3096.
        https://doi.org/10.3390/cancers13123096
    
    APA Style
    
                                Ahn, B.-C.,                                 Lee, J. H.,                                 Kim, M. H.,                                 Pyo, K.-H.,                                 Lee, C.-k.,                                 Lim, S. M.,                                 Kim, H. R.,                                 Cho, B. C.,                                 & Hong, M. H.        
        
        (2021). Distinct Characteristics and Clinical Outcomes to Predict the Emergence of MET Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Cancers, 13(12), 3096.
        https://doi.org/10.3390/cancers13123096